ClinConnect ClinConnect Logo
Search / Trial NCT02593565

Vasculitis Pregnancy Registry

Launched by UNIVERSITY OF PENNSYLVANIA · Oct 29, 2015

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

The Vasculitis Pregnancy Registry is a study aimed at understanding the experiences of women with various types of vasculitis who are pregnant. Vasculitis refers to a group of diseases that cause inflammation of the blood vessels, which can affect different parts of the body. In this study, researchers want to gather information through online surveys about how each woman's condition affects her pregnancy and what the outcomes of these pregnancies are. This information will help improve care and support for women with vasculitis during pregnancy.

To be eligible for this study, women must be 18 years or older, currently pregnant, and have a diagnosed condition from a specific list of vasculitis diseases. Participants will complete online surveys that ask about their health and pregnancy experiences. The study is open to women who speak English, Spanish, Portuguese, Italian, or Turkish. If you are eligible and choose to participate, your experiences could provide valuable insights for others in similar situations.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Women 18 years of age or older with one of the following diseases may take part in the study:
  • Behçet's disease;
  • Central nervous system (CNS) vasculitis;
  • Cryoglobulinemic vasculitis (Cryoglobulinemia);
  • Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
  • Giant Cell (Temporal) Arteritis (GCA);
  • Granulomatosis with polyangiitis (also called Wegener's);
  • IgA vasculitis (Henoch-Schoenlein purpura);
  • Microscopic polyangiitis (MPA);
  • Polyarteritis nodosa (PAN);
  • Takayasu's arteritis (TAK);
  • Urticarial vasculitis;
  • Other/Suspected Diagnosis.
  • 2. Women must be pregnant (self-report) at the time of enrollment into the registry.
  • Exclusion Criteria:
  • 1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.
  • 2. Unable to provide consent.

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Tampa, Florida, United States

Patients applied

0 patients applied

Trial Officials

Megan Clowse, MD, MPH

Study Chair

Duke University

Peter A Merkel, MD, MPH

Study Chair

University of Pennsylvania

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials